...
机译:酪蛋白激酶1是慢性淋巴细胞白血病中的治疗靶标
Masaryk Univ Fac Sci Inst Expt Biol Kotlarska 2 CS-61137 Brno Czech Republic;
Masaryk Univ Fac Sci Inst Expt Biol Kotlarska 2 CS-61137 Brno Czech Republic;
Vet Res Inst Dept Chem &
Toxicol Brno Czech Republic;
Masaryk Univ Fac Sci Inst Expt Biol Kotlarska 2 CS-61137 Brno Czech Republic;
Masaryk Univ Fac Sci Inst Expt Biol Kotlarska 2 CS-61137 Brno Czech Republic;
Vet Res Inst Dept Chem &
Toxicol Brno Czech Republic;
Univ Hosp Brno Dept Internal Med Hematol Oncol Ctr Mol Biol &
Gene Therapy Brno Czech Republic;
Masaryk Univ Fac Sci Inst Expt Biol Kotlarska 2 CS-61137 Brno Czech Republic;
Masaryk Univ Inst Biostat &
Anal Brno Czech Republic;
Masaryk Univ Fac Sci Inst Expt Biol Kotlarska 2 CS-61137 Brno Czech Republic;
Masaryk Univ Fac Sci Inst Expt Biol Kotlarska 2 CS-61137 Brno Czech Republic;
Acad Sci Czech Republ Inst Biophys Brno Czech Republic;
St Annes Univ Hosp Brno Ctr Biomol &
Cellular Engn Int Clin Res Ctr Brno Czech Republic;
Masaryk Univ Fac Sci Inst Expt Biol Kotlarska 2 CS-61137 Brno Czech Republic;
Paracelsus Med Univ Salzburg Austria;
Univ Hosp Brno Dept Internal Med Hematol Oncol Ctr Mol Biol &
Gene Therapy Brno Czech Republic;
Univ Hosp Brno Dept Internal Med Hematol Oncol Ctr Mol Biol &
Gene Therapy Brno Czech Republic;
Univ Hosp Brno Dept Internal Med Hematol Oncol Ctr Mol Biol &
Gene Therapy Brno Czech Republic;
Univ Hosp Brno Dept Internal Med Hematol Oncol Ctr Mol Biol &
Gene Therapy Brno Czech Republic;
Masaryk Univ Fac Sci Inst Expt Biol Kotlarska 2 CS-61137 Brno Czech Republic;
机译:酪蛋白激酶1是慢性淋巴细胞白血病中的治疗靶标
机译:PKCbeta对于TCL1转基因小鼠模型中慢性淋巴细胞性白血病的发展至关重要:验证PKCbeta作为慢性淋巴细胞性白血病的治疗靶标。
机译:蛋白激酶:慢性淋巴细胞白血病的新兴治疗靶点
机译:基于蛋白质组学的临床多激酶抑制剂诱导肾凋亡凋亡的靶碎屑(CLL)
机译:激酶靶向疗法在慢性淋巴细胞性白血病中:获得性依鲁替尼耐药性的机制和OSU-T315的临床前开发。
机译:布鲁顿酪氨酸激酶代表了治疗慢性淋巴细胞性白血病的有希望的治疗靶标并被PCI-32765有效靶向
机译:酪蛋白激酶1是慢性淋巴细胞白血病中的治疗靶标